Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 34, 2011, Pages 14222-14227

  Nakahama, Taisuke ^a   Kimura, Akihiro ^b   Trung Nguyen, Nam ^a   Chinen, Ichino ^a   Hanieh, Hamza ^a   Nohara, Keiko ^c   Fujii Kuriyama, Yoshiaki ^d   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Dioxin receptor; Immune regulation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COLLAGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROMATIC HYDROCARBON RECEPTOR DEFICIENCY; ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE SILENCING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE; CELL DIFFERENTIATION; INFLAMMATION; INFLAMMATION MEDIATORS; INTEGRASES; JOINTS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES; TH17 CELLS;

MUS;

EID: 80052155367     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111786108     Document Type: Article

References (42)

1. Harris ED, Jr. (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322:1277-1289.
2. Maini R, et al.; ATTRACT Study Group (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. Lancet 354:1932-1939.
3. Weinblatt ME, et al. (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259. (Pubitemid 29063266)
4. Weinblatt ME, et al. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35-45. (Pubitemid 36091645)
5. Okuda Y (2008) Review of tocilizumab in the treatment of rheumatoid arthritis. Biologics 2:75-82.
6. Emery P, et al. (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67:1516-1523.
7. Smolen JS, et al.; OPTION Investigators (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebo-controlled, randomised trial. Lancet 371:987-997.
8. Langrish CL, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-240. (Pubitemid 40189432)
9. Harrington LE, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132. (Pubitemid 41541790)
10. Park H, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133-1141. (Pubitemid 41541791)
11. Nakae S, et al. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100:5986-5990. (Pubitemid 36576918)
12. Hirota K, et al. (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204:41-47. (Pubitemid 46148754)
13. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
14. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942-949. (Pubitemid 47300008)
15. Fujimoto M, et al. (2008) Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 58:3710-3719.
16. Iwanami K, et al. (2008) Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum 58:754-763. (Pubitemid 351364873)
17. Trentham DE (1982) Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum 25:911-916.
18. Stuart JM, Townes AS, Kang AH (1984) Collagen autoimmune arthritis. Annu Rev Immunol 2:199-218.
19. Terato K, et al. (1992) Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103-2108.
20. Burbach KM, Poland A, Bradfield CA (1992) Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89:8185-8189.
21. Ema M, et al. (1992) cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun 184:246-253.
22. Fujii-Kuriyama Y, Ema M, Mimura J, Sogawa K (1994) Ah receptor: A novel ligand-activated transcription factor. Exp Clin Immunogenet 11:65-74. (Pubitemid 24305626)
23. Esser C, Rannug A, Stockinger B (2009) The aryl hydrocarbon receptor in immunity. Trends Immunol 30:447-454.
24. Quintana FJ, et al. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71. (Pubitemid 351630328)
25. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2008) Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105:9721-9726. (Pubitemid 352031367)
26. Veldhoen M, et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-109. (Pubitemid 351630329)
27. Kimura A, et al. (2009) Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206:2027-2035.
28. Wooley PH, Luthra HS, Stuart JM, David CS (1981) Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154:688-700. (Pubitemid 11060781)
29. Seeuws S, et al. (2010) A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res Ther 12:R160 10.1186/ar3119.
30. Yoshihara Y, et al. (1995) Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 38:969-975.
31. Wang W, et al. (2011) The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 10.1007/s00296-010-1710-0.
32. Boissier MC, Assier E, Falgarone G, Bessis N (2008) Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 75:373-375.
33. Takamura T, et al. (2010) Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol 88:685-689.
34. Sekine H, et al. (2009) Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 29:6391-6400.
35. Kobayashi S, et al. (2008) A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47:1317-1322.
36. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429-442. (Pubitemid 46834849)
37. Sarkar S, et al. (2009) Regulation of pathogenic IL-17 responses in collagen-induced arthritis: Roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 11:R158.
38. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511. (Pubitemid 38931765)
39. Nguyen NT, et al. (2010) Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 107:19961-19966.
40. Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2:1269-1275. (Pubitemid 46901304)
41. Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537-3545.
42. Campbell IK, Hamilton JA, Wicks IP (2000) Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568-1575. (Pubitemid 30342798)